DaVita Clinical Research Welcomes New Medical Director to Minneapolis Center

  DaVita Clinical Research Welcomes New Medical Director to Minneapolis Center

Business Wire

MINNEAPOLIS -- February 25, 2013

DaVita Clinical Research® (DCR®), a specialty contract research organization
with services spanning the full spectrum of drug and device development,
announced today that Dr. Jolene K. Berg, M.D., has been appointed medical
director of the DaVita Clinical Research Phase I center in Minneapolis.

“Dr. Berg brings a depth of experience in clinical trial design and execution
in a wide range of early clinical studies,” said Amy Young, vice president and
general manager of DCR. “Her experience augments DCR’s capabilities to manage
co-morbid conditions in early clinical trials. She will be responsible for
overseeing all clinical aspects of Phase I trials and providing medical
monitoring services across study sites.”

Dr. Berg will serve as principal investigator for Phase I-IIa studies being
conducted in DCR’s inpatient site. Previously Dr. Berg was director of medical
affairs at PRACS Institute, where she was responsible for the planning and
development of clinical studies in Phase I through Phase IV with an emphasis
on endocrinology and innovator drugs.

“I am excited to join the early clinical research unit at DCR,” said Dr. Berg.
“I look forward to contributing to their long-standing history of providing
operational and scientific excellence.”

Dr. Berg completed her medical degree at the University of Minnesota Medical
School in Minneapolis; she fulfilled a family medicine residency training at
St. John’s Hospital in St. Paul, Minn., and at the University of Washington in
Seattle. Dr. Berg is also a Certified Physician Investigator through the
Academy of Pharmaceutical Physicians and Investigators.

To learn more about DCR and upcoming clinical research trials, visit
participateDaVita.com or DCR on Facebook.

DaVita, DaVita Clinical Research and DCR are registered trademarks of DaVita
HealthCare Partners Inc. All other trademarks are the property of their
respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune
500® company that, through its operating divisions, provides a variety of
health care services to patient populations throughout the United States and
abroad. A leading provider of kidney care in the United States, DaVita
delivers dialysis services to patients with chronic kidney failure and end
stage renal disease. DaVita strives to improve patients’ quality of life by
innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of
December 31, 2012, DaVita operated or provided administrative services at
1,954 outpatient dialysis centers located in the United States serving
approximately 153,000 patients. The company also operated 36 outpatient
dialysis centers located in eight countries outside the United States. DaVita
supports numerous programs dedicated to creating positive, sustainable change
in communities around the world. The company’s leadership development
initiatives and social responsibility efforts have been recognized by Fortune,
Modern Healthcare, Newsweek and WorldBlu. For more information, please visit
DaVita.com.

About DaVita Clinical Research (DCR)

DaVita Clinical Research(DCR), a wholly owned subsidiary ofDaVita HealthCare
Partners, Inc.,uses its extensive, applied database and real-world healthcare
experience to assist pharmaceutical and medical device companies in the
design, recruitment and completion of retrospective,prospective pragmatic and
clinicaltrials.DCR’s scientific and clinical expertise spans the lifecycle
of product development with more than 150 client companies.
DCR’sBiorepository,Early Clinical Researchunit (Phase I-IIa) andClinical
Development (Phase IIb through post-marketing)network of physicians and
investigative sites, data research,Health Economics & Outcomes
Research,Central Laboratory, andMedical Communicationsare focused on
providing world-class research in both complex/specialty populations and
therapeutic areas, and especially in CKD and ESRD populations. To learn more
about DCR, visitwww.davitaclinicalresearch.com.

Contact:

DaVita
Bianca Violante, 303-876-6614
Mobile: 443-417-6044
Bianca.Violante@DaVita.com
 
Press spacebar to pause and continue. Press esc to stop.